SCHEMBL17829291

SCHEMBL17829291

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cccc5c(-c6ccc(-c7ccccn7)cc6)cccc45)cc3)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.48
TDP1 Q9NUW8 2/20 0.48
HSD17B10 Q99714 3/20 0.47
MAPK1 P28482 3/20 0.47
TSHR P16473 2/20 0.47
DHODH Q02127 1/20 0.47
SMN1; SMN2 Q16637 6/20 0.46
RAB9A P51151 6/20 0.46
NPC1 O15118 5/20 0.46
METAP1 P53582 1/20 0.46
HPGD P15428 5/20 0.46
TP53 P04637 4/20 0.46
ALDH1A1 P00352 4/20 0.46
MAPT P10636 4/20 0.46
LMNA P02545 4/20 0.45
PKM P14618 2/20 0.45
KLF5 Q13887 1/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
ALPL P05186 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17598615 0.97 KDM4E (0.50) KDM4ETDP1HSD17B10MAPK1TSHR
SCHEMBL17829306 0.95 KDM4E (0.50) KDM4ETDP1HSD17B10MAPK1TSHR
SCHEMBL20195361 0.92 KDM4E (0.44) KDM4ETDP1HSD17B10MAPK1TSHR
SCHEMBL17829422 0.92 KDM4E (0.52) KDM4ETDP1HSD17B10MAPK1TSHR
SCHEMBL19168467 0.92 SMN1; SMN2 (0.41) KDM4ETDP1HSD17B10MAPK1TSHR
SCHEMBL21099079 0.90 HSD17B10 (0.48) KDM4EHSD17B10MAPK1TSHRDHODH
SCHEMBL17598658 0.89 SMN1; SMN2 (0.43) KDM4ETDP1HSD17B10MAPK1TSHR
SCHEMBL17598622 0.89 TNF (0.43) KDM4ETDP1HSD17B10MAPK1TSHR
SCHEMBL21317589 0.89 ALDH1A1 (0.49) KDM4ETDP1HSD17B10MAPK1TSHR
SCHEMBL17720989 0.89 KDM4E (0.55) KDM4ETDP1HSD17B10MAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11211563-B2 Organic light emitting device LG CHEM, LTD. (KR) 2021-12-28 US disclosed
US-20190198766-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2019-06-27 US disclosed
US-20160172598-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2016-06-16 US disclosed
US-20160172598-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172598-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME CRY1, CRY2, PER2 KDM4E 1590/4885TDP1 1611/4885HSD17B10 1853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.